Host Proteome Research in HIV Infection

Genomics, Proteomics and Bioinformatics

Volumn 8, Issue 1, 2010, Pages 1-9

  Zhang, Lijun ^a,c   Zhang, Xiaojun ^b   Ma, Qing ^d   Zhou, Honghao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b FUZHOU GENERAL HOSPITAL   (China)

^c FUDAN UNIVERSITY   (China)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

biomarker; HIV; HIV host interaction; proteomics

Indexed keywords

BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; HAPTOGLOBIN; HEMOPEXIN; LACTOFERRIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RETINOL BINDING PROTEIN; TRANSFERRIN;

AIDS PATIENT; APOPTOSIS; CHILDHOOD DISEASE; CLINICAL RESEARCH; COGNITIVE DEFECT; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE MODEL; FETOPLACENTAL UNIT; HIV ASSOCIATED DEMENTIA; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLAMMATION; KIDNEY BIOPSY; KIDNEY DISEASE; MICROENVIRONMENT; MOLECULAR CLONING; NONHUMAN; OXIDATIVE STRESS; PROSTITUTION; PROTEOMICS; REVIEW; RISK ASSESSMENT; SUBSTANCE ABUSE; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS RESISTANCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS DEMENTIA COMPLEX; ANIMALS; FORECASTING; HIV; HIV INFECTIONS; HUMANS; PROTEOME; PROTEOMICS; RESEARCH; SUBSTANCE-RELATED DISORDERS;

EID: 77951694943     PISSN: 16720229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1672-0229(10)60001-0     Document Type: Review

References (62)

1. List E.O., et al. The use of proteomics to study infectious diseases. Infect. Disord. Drug Targets 8 (2008) 31-45
2. Noorbakhsh F., et al. Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology. Trends Neurosci. 32 (2009) 88-100
3. Wiederin J., et al. Biomarkers of HIV-1 associated dementia: proteomic investigation of sera. Proteome Sci. 7 (2009) 8
4. Kim S.S., et al. Different isoforms of apolipoprotein AI present heterologous post-translational expression in HIV infected patients. J. Proteome Res. 6 (2007) 180-184
5. Pendyala G., et al. Cerebrospinal fluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys. J. Proteome Res. 8 (2009) 2253-2260
6. Bonneh-Barkay D., et al. YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor. Am. J. Pathol. 173 (2008) 130-143
7. Ringrose J.H., et al. Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1. J. Virol. 82 (2008) 4320-4330
8. Velazquez I., et al. Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment. J. Neuroimmunol. 206 (2009) 106-111
9. Burgener A., et al. Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers. J. Proteome Res. 7 (2008) 4446-4454
10. Jain M.R., et al. Quantitative proteomic analysis of formalin fixed paraffin embedded oral HPV lesions from HIV patients. Open Proteomics J. 1 (2008) 40-45
11. Garcia K., et al. Characterization of the placental macrophage secretome: implications for antiviral activity. Placenta 30 (2009) 149-155
12. Rasheed S., et al. HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study. PLoS One 3 (2008) e3003
13. Chan E.Y., et al. Dynamic host energetics and cytoskeletal proteomes in human immunodeficiency virus type 1-infected human primary CD4 cells: analysis by multiplexed label-free mass spectrometry. J. Virol. 83 (2009) 9283-9295
14. Wang T., et al. Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk. PLoS One 3 (2008) e2507
15. Wang T., et al. HIV-1-infected astrocytes and the microglial proteome. J. Neuroimmune Pharmacol. 3 (2008) 173-186
16. Rasheed S., et al. Proteomic characterization of HIV-modulated membrane receptors, kinases and signaling proteins involved in novel angiogenic pathways. J. Transl. Med. 7 (2009) 75
17. Kadiu I., et al. HIV-1 transforms the monocyte plasma membrane proteome. Cell Immunol. 258 (2009) 44-58
18. Kadiu I., et al. Cytoskeletal protein transformation in HIV-1-infected macrophage giant cells. J. Immunol. 178 (2007) 6404-6415
19. Simpson R.J., et al. Proteomic profiling of exosomes: current perspectives. Proteomics 8 (2008) 4083-4099
20. Peraire J., et al. HIV-1-infected long-term non-progressors have milder mitochondrial impairment and lower mitochondrially-driven apoptosis in peripheral blood mononuclear cells than typical progressors. Curr. HIV Res. 5 (2007) 467-473
21. Ances B.M., and Ellis R.J. Dementia and neurocognitive disorders due to HIV-1 infection. Semin. Neurol. 27 (2007) 86-92
22. Laspiur J.P., et al. CSF proteomic fingerprints for HIV-associated cognitive impairment. J. Neuroimmunol. 192 (2007) 157-170
23. Rozek W., et al. Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. J. Proteome Res. 6 (2007) 4189-4199
24. Soler-Garcia A.A., et al. Iron-related proteins: candidate urine biomarkers in childhood HIV-associated renal diseases. Clin. J. Am. Soc. Nephrol. 4 (2009) 763-771
25. Rawson P.M., et al. Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection. Nat. Med. 13 (2007) 1431-1439
26. Pathak S., et al. HIV induces both a down-regulation of IRAK-4 that impairs TLR signalling and an up-regulation of the antibiotic peptide dermcidin in monocytic cells. Scand. J. Immunol. 70 (2009) 264-276
27. Brass A.L., et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319 (2008) 921-926
28. Dyer M.D., et al. The landscape of human proteins interacting with viruses and other pathogens. PLoS Pathog. 4 (2008) e32
29. Douglas J.L., et al. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J. Virol. 83 (2009) 7931-7947
30. Lee M.J., and Park J.H. Pathway analysis in HEK 293T cells overexpressing HIV-1 tat and nucleocapsid. J. Microbiol. Biotechnol. 19 (2009) 1103-1108
31. Gautier V.W., et al. In vitro nuclear interactome of the HIV-1 Tat protein. Retrovirology 6 (2009) 47
32. He F., et al. Endogenous HIV-1 Vpr-mediated apoptosis and proteome alteration of human T-cell leukemia virus-1 transformed C8166 cells. Apoptosis 14 (2009) 1212-1226
33. Srivastava S., et al. Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog. 4 (2008) e1000059
34. Gonzalez-Scarano F., and Martin-Garcia J. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5 (2005) 69-81
35. Power C. Retroviral diseases of the nervous system: pathogenic host response or viral gene-mediated neurovirulence?. Trends Neurosci. 24 (2001) 162-169
36. Kaul M., and Lipton S.A. Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr. HIV Res. 4 (2006) 307-318
37. Toro-Nieves D.M., et al. Proteomic analyses of monocyte-derived macrophages infected with human immunodeficiency virus type 1 primary isolates from Hispanic women with and without cognitive impairment. J. Neurovirol. 15 (2009) 36-50
38. Ricardo-Dukelow M., et al. HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia. J. Neuroimmunol. 185 (2007) 37-46
39. Gelman B.B., and Nguyen T.P. Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes. J. Neuroimmune Pharmacol. 5 (2010) 92-102
40. Iqbal S.M., et al. Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition. AIDS 23 (2009) 1669-1677
41. Luciano-Montalvo C., et al. Proteomic analyses associate cystatin B with restricted HIV-1 replication in placental macrophages. Placenta 29 (2008) 1016-1023
42. Reynolds J.L., et al. Proteomic analyses of the effects of drugs of abuse on monocyte-derived mature dendritic cells. Immunol. Invest. 38 (2009) 526-550
43. Reynolds J.L., et al. Modulation of the proteome of peripheral blood mononuclear cells from HIV-1-infected patients by drugs of abuse. J. Clin. Immunol. 29 (2009) 646-656
44. Haase A.T. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464 (2010) 217-223
45. Grandy, S.A., et al. 2010. Reduction of ventricular sodium current in a mouse model of HIV. J. Cardiovasc. Electrophysiol. In press.
46. Denton P.W., et al. Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS One 5 (2010) e8829
47. Hag A.M., et al. Regional gene expression of LOX-1, VCAM-1, and ICAM-1 in aorta of HIV-1 transgenic rats. PLoS One 4 (2009) e8170
48. Peng J., et al. The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J. Neuroimmunol. 218 (2010) 94-101
49. Collins C.E., et al. A rapid and reliable method of counting neurons and other cells in brain tissue: a comparison of flow cytometry and manual counting methods. Front. Neuroanat. 4 (2010) 5
50. Ibrahim S.F., and van de Engh G. Flow cytometry and cell sorting. Adv. Biochem. Eng. Biotechnol. 106 (2007) 19-39
51. Kunz, F., et al. 2010. A novel modular device for 3-D bone cell culture and non-destructive cell analysis. Acta Biomater. In press.
52. Helbig A.O., et al. Exploring the membrane proteome-challenges and analytical strategies. J. Proteomics 73 (2010) 868-878
53. Picotti P., et al. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 138 (2009) 795-806
54. Graham D.R., et al. Two-dimensional gel-based approaches for the assessment of N-Linked and O-GlcNAc glycosylation in human and simian immunodeficiency viruses. Proteomics 8 (2008) 4919-4930
55. Latterich M., et al. Proteomics: new technologies and clinical applications. Eur. J. Cancer 44 (2008) 2737-2741
56. Zamo A., and Cecconi D. Proteomic analysis of lymphoid and haematopoietic neoplasms: there's more than biomarker discovery. J. Proteomics 73 (2010) 508-520
57. Sun S., et al. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways. Liver Int. 27 (2007) 1021-1038
58. Psyrri, A., et al. 2010. Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee. Ann. Oncol. In press.
59. Cho W.C. Proteomics technologies and challenges. Genomics Proteomics Bioinformatics 5 (2007) 77-85
60. Thomas, C. and Moridani, M. 2009. Interindividual variations in the efficacy and toxicity of vaccines. Toxicology. In press.
61. Regnstrom K.J. Pharmacogenomics in the preclinical development of vaccines: evaluation of efficacy and systemic toxicity in the mouse using array technology. Methods Mol. Biol. 448 (2008) 447-467
62. Lucchese A., et al. Sequence uniqueness as a molecular signature of HIV-1-derived B-cell epitopes. Int. J. Immunopathol. Pharmacol. 22 (2009) 639-646